Data / Form D filings / Novamind Ventures Inc.
Novamind Ventures Inc.: Form D filing
Novamind Ventures Inc., a biotechnology company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2020. The latest, on November 25, 2020, reports $2.2 million sold of a $2.2 million offering to 13 investors.
Find out what Novamind Ventures Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 WANLESS AVE, SUITE 201, Toronto, Ontario, Canada, M4N 1
- Phone
- (647) 953-9512
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1833397
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2020 | New notice | $2,153,247 | $2,153,247 | $0 | 13 | Nov 10, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Reid Robison | Executive Officer, Director | |
| Jesse Kaplan | Director | |
| Yisroel Weinreb | Executive Officer, Director | |
| Yaron Conforti | Executive Officer, Director |
Every Form D from the week of Nov 23, 2020 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Novamind Ventures Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.